LB Pharmaceuticals Inc (LBRX)

NasdaqGM: LBRX · Real-Time Price · USD

45.38

+0.05 (0.11%)

At close: Aug 12, 2026, 3:59 PM

45.00

-0.84%

After-hours: 7:34 PM

Statistics

Share Statistics

LB Pharmaceuticals Inc has 32.26M shares outstanding. The shares have a market value of 1.46B.

Shares Outstanding	32.26M
Shares Change (YoY)	127.22%
Shares Change (QoQ)	11.16%
Owned by Institutions (%)	109.45%
Shares Floating	20.29M
Failed to Deliver (FTD) Shares	2,408
FTD / Avg. Volume	n/a

Short Selling Information

Short interest in LB Pharmaceuticals Inc is 16.55% of the outstanding shares, representing 4.75M shares. The short ratio is 14.95.

Short Interest	4.75M
Short % of Shares Out	16.55%
Short % of Float	19.92%
Short Ratio (days to cover)	14.95

Valuation Ratios

PE Ratio	n/a
Forward PE	-9.17
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.44
P/FCF Ratio	-29.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The enterprise value is 1.14B. Enterprise value adds debt and subtracts cash from the company's market cap, providing an alternative valuation for the company.

EV / Sales	n/a
EV / EBITDA	-12.16
EV / EBIT	-22.66
EV / FCF	-22.63

Financial Position

LB Pharmaceuticals Inc's current ratio is 15.08. A current ratio above 1 means that the company has enough short-term assets to cover its short-term liabilities.

Current Ratio	15.08
Quick Ratio	13.91
Debt / Equity	0.01
Debt / EBITDA	-0.08
Debt / FCF	-0.07
Interest Coverage

Financial Efficiency

Return on Equity is -50%, and return on invested capital is -12.06%.

Return on Equity	-50%
Return on Assets	-30.92%
Return on Invested Capital	-12.06%
Revenue Per Employee	n/a
Profits Per Employee	$-1.44M
Employee Count	27
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	1K
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 162.02% in the past year.

Beta
52-Week Price Change	162.02%
50-Day Moving Average	33.81
200-Day Moving Average	25.83
Relative Strength Index (RSI)	78.99
Average Volume (20 Days)	307,109

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-46.08M
Net Income	-38.95M
EBITDA	-45.76M
EBIT	-46.08M
Earnings Per Share (EPS)	-5.1

Full Income Statement

Balance Sheet

LB Pharmaceuticals Inc has 320.68M in cash on the balance sheet. Total assets are 393.48M, and total liabilities are 3.47M.

Cash & Cash Equivalents	320.68M
Total Debt	3.47M
Net Cash	317.21M
Retained Earnings	-148.58M
Total Assets	393.48M
Working Capital	378.17M

Full Balance Sheet

Cash Flow

LB Pharmaceuticals Inc's operating cash flow was -50.37M over the trailing twelve months.

Operating Cash Flow	-50.37M
Capital Expenditures	-63K
Free Cash Flow	-50.43M
FCF Per Share	-1.563

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	0%
Earnings Yield	-11.24%
FCF Yield	-3.45%

Dividend Details

Analyst Forecast

According to 8 stock analysts, the average 12-month price target for LB Pharmaceuticals Inc is $42.5. The average analyst rating is "Strong Buy".

Price Target	$42.5
Price Target Difference	-6.35%
Analyst Consensus	Strong Buy
Analyst Count	8

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the fair value of a stock, including the Graham Number and Lynch Fair Value methods.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	59.63
Piotroski F-Score	3